Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J L Lombrana
Treatment of Chronic Hepatitis C With Recombinant Interferon Alfa-2b for Nine Months.
Gut
Gastroenterology
Related publications
Low Dose Interferon Alfa-2b for Chronic Hepatitis B in Asian Countries.
Gut
Gastroenterology
Incidence of Thyroid Dysfunction During Interferon Alfa-2b and Ribavirin Therapy in Men With Chronic Hepatitis C
Archives of Internal Medicine
Hepatitis C Virus Markers in Patients With Acute Post-Transfusion Hepatitis Treated With Interferon Alfa-2b.
Gut
Gastroenterology
PGI18 Treatment of Chronic Hepatitis C Patients With Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS Setting
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness Analysis of Treatment With Peginterferon-Alfa-2a Versus Peginterferon-Alfa-2b for Patients With Chronic Hepatitis C Under the Public Payer Perspective in Brazil
Cost Effectiveness and Resource Allocation
Health Policy
Pseudouridine for Monitoring Interferon Treatment of Patients With Chronic Hepatitis C
Clinical Chemistry and Laboratory Medicine
Biochemistry
Medicine
Clinical Biochemistry
Peginterferon Alfa-2b and Ribavirin Therapy in Kuwaiti Patients With Chronic Hepatitis C Virus Infection
Eastern Mediterranean Health Journal
Medicine
Oxidative Stress and Antioxidant Defense in Patients With Chronic Hepatitis C Patients Before and After Pegylated Interferon Alfa-2b Plus Ribavirin Therapy
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Treatment of Biopsy Proved Conjunctival Intraepithelial Neoplasia With Topical Interferon Alfa-2b
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
